The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AVENANCE real-world study of avelumab first-line (1L) maintenance treatment for advanced urothelial carcinoma (UC): Analyses in low tumor burden subgroups.
 
Philippe Barthelemy
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Constance Thibault
Honoraria - AAA/Endocyte/Novartis; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer; Sanofi; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; AstraZeneca; Bristol-Meyers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Pfizer
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Eric Voog
No Relationships to Disclose
 
Jean Christophe Eymard
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst); Pfizer (Inst)
 
Camille Simon
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; Pfizer; Seagen
 
Damien Pouessel
Honoraria - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer/Astellas
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb/Medarex; Eisai; Merck; MSD Oncology; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Pfizer
 
Matthieu Chasseray
Honoraria - AstraZeneca; Merck KGaA
Consulting or Advisory Role - Merck KGaA
Travel, Accommodations, Expenses - Astellas Pharma; Daiichi Sankyo; Ipsen; Lilly; Merck KGaA
 
Veronique Lorgis
No Relationships to Disclose
 
Constant Josse
Employment - eXYSTAT
Research Funding - Merck KGaA (Inst); Pfizer (Inst)
 
Prisca Lambert
Employment - Pfizer
 
Laurent Paret
Employment - Merck KGaA
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Gilead Sciences; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - Astrazeneca (Inst); Astrazeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; Ipsen; ipsen; ipsen; ipsen; Janssen-Cilag; MSD Oncology; MSD Oncology; pfizer; Pfizer; Roche